Literature DB >> 21085059

Single-nucleotide polymorphisms, acute rejection, and severity of tubulitis in kidney transplantation, accounting for center-to-center variation.

Ajay Israni1, Robert Leduc, John Holmes, Pamala A Jacobson, Vishal Lamba, Weihua Guan, David Schladt, Jinbo Chen, Arthur J Matas, William S Oetting.   

Abstract

BACKGROUND: Acute rejection (AR) is associated with worse renal allograft outcomes. Therefore, this study investigated single-nucleotide polymorphisms (SNPs) to identify genetic variants associated with AR, accounting for center variation, in a multicenter, prospective, observation study.
METHODS: We enrolled patients from six transplant centers, five in the United States and one in Canada. A total of 2724 SNPs were genotyped. We accounted for center variation in AR rates by stratifying by transplant center and using novel knowledge discovery methods.
RESULTS: There was significant center variation in AR rates across the six transplant sites (P<0.0001). Accounting for this difference and clinical factors independently associated with AR, we identified 15 novel SNPs associated with AR with stratification by transplant center (P<0.05). We also identified 15 novel SNPs associated with severity of tubulitis scores, after adjusting for transplant center and other clinical factors independently associated with severity of tubulitis (P<0.05). There was some overlap with one SNP associated with AR and also associated with severity of tubulitis, among the top 15 SNPs.
CONCLUSION: Center-to-center variation is a major challenge to genomic studies focused on AR. The SNPs associated with AR and severity of tubulitis in this study will need to be validated in independent cohort of kidney transplant recipients.

Entities:  

Mesh:

Year:  2010        PMID: 21085059      PMCID: PMC3594840          DOI: 10.1097/TP.0b013e3182000085

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  18 in total

Review 1.  Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy.

Authors:  T A Waldmann; S Dubois; Y Tagaya
Journal:  Immunity       Date:  2001-02       Impact factor: 31.745

2.  Multiplexed genotyping with sequence-tagged molecular inversion probes.

Authors:  Paul Hardenbol; Johan Banér; Maneesh Jain; Mats Nilsson; Eugeni A Namsaraev; George A Karlin-Neumann; Hossein Fakhrai-Rad; Mostafa Ronaghi; Thomas D Willis; Ulf Landegren; Ronald W Davis
Journal:  Nat Biotechnol       Date:  2003-05-05       Impact factor: 54.908

3.  Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas.

Authors:  Wayne Tam; Mario Gomez; Amy Chadburn; Joong W Lee; Wing C Chan; Daniel M Knowles
Journal:  Blood       Date:  2006-01-19       Impact factor: 22.113

4.  The structure of the interleukin-15 alpha receptor and its implications for ligand binding.

Authors:  Inken Lorenzen; Andrew J Dingley; Yannick Jacques; Joachim Grötzinger
Journal:  J Biol Chem       Date:  2005-12-23       Impact factor: 5.157

5.  IMPDH1 gene polymorphisms and association with acute rejection in renal transplant patients.

Authors:  J Wang; J W Yang; A Zeevi; S A Webber; D M Girnita; R Selby; J Fu; T Shah; V Pravica; I V Hutchinson; G J Burckart
Journal:  Clin Pharmacol Ther       Date:  2007-09-12       Impact factor: 6.875

6.  Time course of response to pulse methylprednisolone therapy in renal transplant recipients with acute allograft rejection.

Authors:  C Shinn; D Malhotra; L Chan; R L Cosby; J I Shapiro
Journal:  Am J Kidney Dis       Date:  1999-08       Impact factor: 8.860

7.  Predicting coronary heart disease after kidney transplantation: Patient Outcomes in Renal Transplantation (PORT) Study.

Authors:  A K Israni; J J Snyder; M A Skeans; Y Peng; J R Maclean; E D Weinhandl; B L Kasiske
Journal:  Am J Transplant       Date:  2010-02       Impact factor: 8.086

8.  Characterization of two distinct dual specificity phosphatases encoded in alternative open reading frames of a single gene located on human chromosome 10q22.2.

Authors:  Hsu-Hsin Chen; Ralf Luche; Bo Wei; Nicholas K Tonks
Journal:  J Biol Chem       Date:  2004-07-13       Impact factor: 5.157

9.  Association of four DNA polymorphisms with acute rejection after kidney transplantation.

Authors:  Josep Grinyó; Yves Vanrenterghem; Björn Nashan; Flavio Vincenti; Henrik Ekberg; Klaus Lindpaintner; Michelle Rashford; Clare Nasmyth-Miller; Athina Voulgari; Olivia Spleiss; Matthew Truman; Laurent Essioux
Journal:  Transpl Int       Date:  2008-04-25       Impact factor: 3.782

10.  Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival.

Authors:  Brian Van Ness; Christine Ramos; Majda Haznadar; Antje Hoering; Jeff Haessler; John Crowley; Susanna Jacobus; Martin Oken; Vincent Rajkumar; Philip Greipp; Bart Barlogie; Brian Durie; Michael Katz; Gowtham Atluri; Gang Fang; Rohit Gupta; Michael Steinbach; Vipin Kumar; Richard Mushlin; David Johnson; Gareth Morgan
Journal:  BMC Med       Date:  2008-09-08       Impact factor: 8.775

View more
  23 in total

1.  Validation of single nucleotide polymorphisms associated with acute rejection in kidney transplant recipients using a large multi-center cohort.

Authors:  William S Oetting; David P Schladt; Robert E Leduc; Pamala A Jacobson; Weihua Guan; Arthur J Matas; Ajay Israni
Journal:  Transpl Int       Date:  2011-09-29       Impact factor: 3.782

2.  Genetic Variants Associated With Immunosuppressant Pharmacokinetics and Adverse Effects in the DeKAF Genomics Genome-wide Association Studies.

Authors:  William S Oetting; Baolin Wu; David P Schladt; Weihua Guan; Jessica van Setten; Brendan J Keating; David Iklé; Rory P Remmel; Casey R Dorr; Roslyn B Mannon; Arthur J Matas; Ajay K Israni; Pamala A Jacobson
Journal:  Transplantation       Date:  2019-06       Impact factor: 4.939

3.  Analysis of 75 Candidate SNPs Associated With Acute Rejection in Kidney Transplant Recipients: Validation of rs2910164 in MicroRNA MIR146A.

Authors:  William S Oetting; David P Schladt; Casey R Dorr; Baolin Wu; Weihua Guan; Rory P Remmel; David Iklé; Roslyn B Mannon; Arthur J Matas; Ajay K Israni; Pamala A Jacobson
Journal:  Transplantation       Date:  2019-08       Impact factor: 4.939

4.  Dosing equation for tacrolimus using genetic variants and clinical factors.

Authors:  Chaitali Passey; Angela K Birnbaum; Richard C Brundage; William S Oetting; Ajay K Israni; Pamala A Jacobson
Journal:  Br J Clin Pharmacol       Date:  2011-12       Impact factor: 4.335

Review 5.  Biomarkers and Pharmacogenomics in Kidney Transplantation.

Authors:  L E Crowley; M Mekki; S Chand
Journal:  Mol Diagn Ther       Date:  2018-10       Impact factor: 4.074

6.  Genomewide Association Study of Tacrolimus Concentrations in African American Kidney Transplant Recipients Identifies Multiple CYP3A5 Alleles.

Authors:  W S Oetting; D P Schladt; W Guan; M B Miller; R P Remmel; C Dorr; K Sanghavi; R B Mannon; B Herrera; A J Matas; D R Salomon; P-Y Kwok; B J Keating; A K Israni; P A Jacobson
Journal:  Am J Transplant       Date:  2015-10-20       Impact factor: 8.086

7.  Genome-wide association study identifies the common variants in CYP3A4 and CYP3A5 responsible for variation in tacrolimus trough concentration in Caucasian kidney transplant recipients.

Authors:  W S Oetting; B Wu; D P Schladt; W Guan; R P Remmel; R B Mannon; A J Matas; A K Israni; P A Jacobson
Journal:  Pharmacogenomics J       Date:  2017-11-21       Impact factor: 3.550

8.  Attempted validation of 44 reported SNPs associated with tacrolimus troughs in a cohort of kidney allograft recipients.

Authors:  William S Oetting; Baolin Wu; David P Schladt; Weihua Guan; Rory P Remmel; Casey Dorr; Roslyn B Mannon; Arthur J Matas; Ajay K Israni; Pamala A Jacobson
Journal:  Pharmacogenomics       Date:  2018-01-10       Impact factor: 2.533

9.  Tacrolimus trough and dose intra-patient variability and CYP3A5 genotype: Effects on acute rejection and graft failure in European American and African American kidney transplant recipients.

Authors:  Stephan R Seibert; David P Schladt; Baolin Wu; Weihua Guan; Casey Dorr; Rory P Remmel; Arthur J Matas; Roslyn B Mannon; Ajay K Israni; William S Oetting; Pamala A Jacobson
Journal:  Clin Transplant       Date:  2018-10-31       Impact factor: 2.863

10.  Inflammation in the setting of chronic allograft dysfunction post-kidney transplant: phenotype and genotype.

Authors:  Ajay K Israni; Robert Leduc; Pamala A Jacobson; Winston Wildebush; Weihua Guan; David Schladt; Arthur J Matas; William S Oetting
Journal:  Clin Transplant       Date:  2013-01-27       Impact factor: 2.863

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.